Biohit Oyj

Director's Dealing • Aug 22, 2017

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, August 22, 2017 at 1:50 pm local time (EEST)

Biohit Oyj has received the following notification.

Person subject to the notification requirement
Name:	Korpela, Semi
Position:	Chief Executive Officer
Initial Notification
Reference number:	74370089ATTSNBXJVT29_20170822114218_4
Issuer
Name:	Biohit Oyj
LEI:	74370089ATTSNBXJVT29
Transaction details
Transaction date:	2017-08-17
Venue:	NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction:	Disposal
Instrument:	Share
ISIN:	FI0009005482
Volume:	500
Unit price:	5,51000 Euro
Volume:	100
Unit price:	5,51000 Euro
Volume:	38
Unit price:	5,52000 Euro
Volume:	300
Unit price:	5,51000 Euro
Volume:	50
Unit price:	5,50000 Euro
Volume:	129
Unit price:	5,50000 Euro
Volume:	500
Unit price:	5,50000 Euro
Volume:	175
Unit price:	5,49000 Euro
Volume:	36
Unit price:	5,49000 Euro
Volume:	588
Unit price:	5,49000 Euro
Volume:	822
Unit price:	5,49000 Euro
Volume:	36
Unit price:	5,49000 Euro
Volume:	36
Unit price:	5,49000 Euro
Volume:	103
Unit price:	5,50000 Euro
Volume:	178
Unit price:	5,49000 Euro
Volume:	35
Unit price:	5,49000 Euro
Volume:	484
Unit price:	5,49000 Euro
Aggregated transactions
Volume:	4110
Volume weighted average price:	5.49656 Euro

Additional information: 

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com